(Yr1) <\/strong>Innovative Technology and Novel Biomarker Discovery and Development for Disease Diagnosis and Treatment (B4D-ARC) (2024-present) <\/strong>\/ Co-Directors: Drs. Weining Lu, Manju Subramanian, Joel Henderson, Liangliang Hao<\/p>\n (Yr2) Tuberculosis Interdisciplinary Approach to Research (2023-present) <\/span><\/strong>\/\u00a0Co-Directors: Drs. Karen Jacobson, Charles ‘Bob’ Horsburgh, Laura White<\/em><\/p>\n (Yr2) Musculoskeletal Biology Over a Lifespan (CeMH) (2023-present) <\/strong>\/\u00a0<\/em>Co-Directors: Drs. Paola Divieti Pajevic, David Felson and <\/em>LaDora Thompson<\/em> Developing an artificial intelligence digital pathology diagnostic tool for proteinuric kidney disease \/ <\/strong>Co-Directors: Drs.\u00a0Weining Lu*\u00a0(primary contact)<\/em>, Chao Zhang, Joel Henderson, William Tomlinson, and Vijaya Kolachalama<\/p>\n A Multi-Disciplinary Program to Identify Predictors of Efficacy and Resistance to Cancer Checkpoint Inhibition (PIPER-C ARC) <\/strong>\/\u00a0<\/em>Co-Directors: Drs. Matthew Kulke, Evan Johnson, David Sherr and Gerald Denis<\/em> Respiratory Viruses: a focus on COVID-19 Program<\/strong> \/ Director: Dr. Markus Bosmann; Co-Director: Dr. Mohsan Saeed<\/em><\/span><\/em><\/span><\/strong><\/p>\n Thrombosis and Hemostasis ARC Program <\/strong>\/\u00a0<\/em>Co-Directors: Drs. Vipul Chitalia, Katya Ravid, Jean Francis<\/em><\/p>\n Precision Medicine for Alzheimer Disease and Related Disorders ARC Program<\/span><\/strong>\u00a0\/\u00a0Co-Directors: Drs. Lindsay Farrer, Rhoda Au and\u00a0<\/em>Alice Cronin-Golom<\/em>b<\/span><\/p>\n Mobile and Electronic (ME)-HealthARC Program <\/span><\/b>\/Director: Dr. Belinda Borrelli; Leadership: Drs. Rebecca Mishuris and Swathi Kiran<\/em><\/p>\n Fibrosis ARC:<\/span><\/strong>\u00a0Connecting Tissues and Investigators (FCTI)ARC Program <\/strong>\/\u00a0Co-Directors: Drs. Maria Trojanowska,\u00a0<\/em><\/span>Irving Bigio\u00a0and Xaralabos ‘Bob’ Varelas\u00a0<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" The Evans Center IBR is pleased to announce the Affinity Research Collaboratives (ARCs) that have been awarded funding for the 2024\/2025 year: ARCs (as of 2024): (Yr1) Innovative Technology and Novel Biomarker Discovery and Development for Disease Diagnosis and Treatment (B4D-ARC) (2024-present) \/ Co-Directors: Drs. Weining Lu, Manju Subramanian, Joel Henderson, Liangliang Hao (Yr2) Tuberculosis […]<\/p>\n","protected":false},"author":1607,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[627],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/evanscenteribr\/wp-json\/wp\/v2\/posts\/4329"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/evanscenteribr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/evanscenteribr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/evanscenteribr\/wp-json\/wp\/v2\/users\/1607"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/evanscenteribr\/wp-json\/wp\/v2\/comments?post=4329"}],"version-history":[{"count":11,"href":"https:\/\/www.bumc.bu.edu\/evanscenteribr\/wp-json\/wp\/v2\/posts\/4329\/revisions"}],"predecessor-version":[{"id":4958,"href":"https:\/\/www.bumc.bu.edu\/evanscenteribr\/wp-json\/wp\/v2\/posts\/4329\/revisions\/4958"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/evanscenteribr\/wp-json\/wp\/v2\/media?parent=4329"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/evanscenteribr\/wp-json\/wp\/v2\/categories?post=4329"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/evanscenteribr\/wp-json\/wp\/v2\/tags?post=4329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/em><\/span><\/strong><\/p>\nBIT-ARC, Year 1 (as of Nov 2024)<\/h5>\n
Continuing ARCs and ARC Programs:
\n<\/em><\/span><\/strong><\/h5>\n
\n<\/em><\/span><\/strong><\/p>\n